Works matching AU Massari, Francesco

Results: 224
    1
    2
    3
    4

    Storage Time and DNA Quality Determine BRCA1/2 Sequencing Success in Prostate Cancer: A Multicentre Analysis with Therapeutic Implications.

    Published in:
    Cancers, 2025, v. 17, n. 10, p. 1705, doi. 10.3390/cancers17101705
    By:
    • Vescovo, Mariavittoria;
    • Raspollini, Maria Rosaria;
    • Nibid, Lorenzo;
    • Castiglione, Francesca;
    • Nardi, Eleonora;
    • de Biase, Dario;
    • Massari, Francesco;
    • Giunchi, Francesca;
    • Pepe, Francesco;
    • Troncone, Giancarlo;
    • Malapelle, Umberto;
    • Carosi, Mariantonia;
    • Casini, Beatrice;
    • Melucci, Elisa;
    • Fassan, Matteo;
    • Toffolatti, Luisa;
    • Guerini-Rocco, Elena;
    • Conversano, Federica;
    • Rappa, Alessandra;
    • Tommasi, Stefania
    Publication type:
    Article
    5
    6
    7

    Human Epidermal Growth Factor Receptor 2--Positive Breast Cancer: Heat Shock Protein 90 Overexpression, Ki67 Proliferative Index, and Topoisornerase II-α Co-amplification as Predictors of Pathologic Complete Response to Neoadjuvant Chemotherapy With Trastuzumab and Docetaxel.

    Published in:
    Clinical Breast Cancer, 2015, v. 15, n. 1, p. 16, doi. 10.1016/j.clbc.2014.05.004
    By:
    • Bria, Emilio;
    • Furlanetto, Jenny;
    • Carbognin, Luisa;
    • Brunelli, Matteo;
    • Caliólo, Chiara;
    • Nortilli, Rolando;
    • Massari, Francesco;
    • Pedron, Serena;
    • Manfrin, Erminia;
    • Pellini, Francesca;
    • Bonetti, Franco;
    • Sperduti, Isabella;
    • Pollini, Giovanni Paolo;
    • Scarpa, Aldo;
    • Tortora, Giampaolo
    Publication type:
    Article
    8
    9

    Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study.

    Published in:
    Clinical Genitourinary Cancer, 2024, v. 22, n. 3, p. N.PAG, doi. 10.1016/j.clgc.2024.102074
    By:
    • Mollica, Veronica;
    • Massari, Francesco;
    • Maruzzo, Marco;
    • Bimbatti, Davide;
    • Claps, Melanie;
    • Maiorano, Brigida Anna;
    • Vitale, Maria Giuseppa;
    • Iacovelli, Roberto;
    • Ermacora, Paola;
    • Roviello, Giandomenico;
    • Calabrò, Fabio;
    • Caffo, Orazio;
    • Vignani, Francesca;
    • Grillone, Francesco;
    • Pierantoni, Francesco;
    • Di Napoli, Marilena;
    • Mennitto, Alessia;
    • Marchetti, Andrea;
    • Mattana, Alvise;
    • Cavo, Alessia
    Publication type:
    Article
    10

    Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study.

    Published in:
    Clinical Genitourinary Cancer, 2024, v. 22, n. 2, p. 305, doi. 10.1016/j.clgc.2023.11.013
    By:
    • Marques Monteiro, Fernando Sabino;
    • Fiala, Ondřej;
    • Massari, Francesco;
    • Myint, Zin W.;
    • Kopecky, Jindrich;
    • Kucharz, Jakub;
    • Büttner, Thomas;
    • Grande, Enrique;
    • Bourlon, Maria Teresa;
    • Molina-Cerrillo, Javier;
    • Pichler, Renate;
    • Buchler, Tomas;
    • Seront, Emmanuel;
    • Ansari, Jawaher;
    • Bamias, Aristotelis;
    • Bhuva, Dipen;
    • Vau, Nuno;
    • Porta, Camillo;
    • Fay, Andre Poisl;
    • Santoni, Matteo
    Publication type:
    Article
    11

    Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1).

    Published in:
    Clinical Genitourinary Cancer, 2023, v. 21, n. 5, p. e309, doi. 10.1016/j.clgc.2023.03.006
    By:
    • Santoni, Matteao;
    • Massari, Francesco;
    • Myint, Zin W.;
    • Iacovelli, Roberto;
    • Pichler, Martin;
    • Basso, Umberto;
    • Kopecky, Jindrich;
    • Kucharz, Jakub;
    • Buti, Sebastiano;
    • Salfi, Alessia;
    • Büttner, Thomas;
    • De Giorgi, Ugo;
    • Kanesvaran, Ravindran;
    • Fiala, Ondřej;
    • Grande, Enrique;
    • Zucali, Paolo Andrea;
    • Fornarini, Giuseppe;
    • Bourlon, Maria T.;
    • Scagliarini, Sarah;
    • Molina-Cerrillo, Javier
    Publication type:
    Article
    12
    13

    Primary Tumor Shrinkage and the Effect on Metastatic Disease and Outcomes in Patients With Advanced Kidney Cancer With Intermediate or Poor Prognosis Treated With Nivolumab Plus Ipilimumab or Cabozantinib.

    Published in:
    Clinical Genitourinary Cancer, 2022, v. 20, n. 5, p. 498.e1, doi. 10.1016/j.clgc.2022.06.006
    By:
    • Iacovelli, Roberto;
    • Ciccarese, Chiara;
    • Maruzzo, Marco;
    • Atzori, Francesco;
    • Galli, Luca;
    • Scagliarini, Sarah;
    • Massari, Francesco;
    • Verzoni, Elena;
    • Cannella, Antonella;
    • Maratta, Maria Grazia;
    • Caserta, Claudia;
    • Bimbatti, Davide;
    • Deppieri, Filippo Maria;
    • Dessi, Mariele;
    • Paolieri, Federico;
    • Riccardi, Ferdinando;
    • Bracarda, Sergio;
    • De Giorgi, Ugo;
    • Basso, Umberto;
    • Tortora, Giampaolo
    Publication type:
    Article
    14
    15

    Nivolumab VERSUS Cabozantinib as Second-Line Therapy in Patients With Advanced Renal Cell Carcinoma: A Real-World Comparison.

    Published in:
    Clinical Genitourinary Cancer, 2022, v. 20, n. 3, p. 285, doi. 10.1016/j.clgc.2022.02.003
    By:
    • Santoni, Matteo;
    • Aurilio, Gaetano;
    • Massari, Francesco;
    • Grande, Enrique;
    • Matrana, Marc R.;
    • Rizzo, Mimma;
    • Giorgi, Ugo De;
    • Incorvaia, Lorena;
    • Martignetti, Angelo;
    • Molina-Cerrillo, Javier;
    • Zabalza, Ignacio Ortego;
    • Mollica, Veronica;
    • Rizzo, Alessandro;
    • Battelli, Nicola;
    • Porta, Camillo
    Publication type:
    Article
    16
    17
    18

    Tp53 and its potential therapeutic role as a target in bladder cancer.

    Published in:
    Expert Opinion on Therapeutic Targets, 2017, v. 21, n. 4, p. 401, doi. 10.1080/14728222.2017.1297798
    By:
    • Ciccarese, Chiara;
    • Massari, Francesco;
    • Blanca, Ana;
    • Tortora, Giampaolo;
    • Montironi, Rodolfo;
    • Cheng, Liang;
    • Scarpelli, Marina;
    • Raspollini, Maria R;
    • Vau, Nuno;
    • Fonseca, Jorge;
    • Lopez-Beltran, Antonio
    Publication type:
    Article
    19
    20
    21

    Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2<sup>EV</sup> Study.

    Published in:
    Targeted Oncology, 2024, v. 19, n. 6, p. 905, doi. 10.1007/s11523-024-01099-0
    By:
    • Fiala, Ondřej;
    • Massari, Francesco;
    • Basso, Umberto;
    • Giannatempo, Patrizia;
    • Grande, Enrique;
    • Buti, Sebastiano;
    • Myint, Zin W.;
    • De Giorgi, Ugo;
    • Pichler, Renate;
    • Grillone, Francesco;
    • Ürün, Yüksel;
    • Calabrò, Fabio;
    • Bourlon, Maria T.;
    • Galli, Luca;
    • Kanesvaran, Ravindran;
    • Roviello, Giandomenico;
    • Kucharz, Jakub;
    • Rizzo, Mimma;
    • Park, Se Hoon;
    • Cerbone, Linda
    Publication type:
    Article
    22

    Pembrolizumab in Patients with Advanced Urothelial Carcinoma with ECOG Performance Status 2: A Real-World Study from the ARON-2 Project.

    Published in:
    Targeted Oncology, 2024, v. 19, n. 5, p. 747, doi. 10.1007/s11523-024-01089-2
    By:
    • Rizzo, Alessandro;
    • Monteiro, Fernando Sabino Marques;
    • Ürün, Yüksel;
    • Massari, Francesco;
    • Park, Se Hoon;
    • Bourlon, Maria T.;
    • Poprach, Alexandr;
    • Rizzo, Mimma;
    • Takeshita, Hideki;
    • Giannatempo, Patrizia;
    • Soares, Andrey;
    • Roviello, Giandomenico;
    • Molina-Cerrillo, Javier;
    • Carrozza, Francesco;
    • Abahssain, Halima;
    • Messina, Carlo;
    • Kopp, Ray Manneh;
    • Pichler, Renate;
    • Formisano, Luigi;
    • Tural, Deniz
    Publication type:
    Article
    23

    Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study).

    Published in:
    Targeted Oncology, 2024, v. 19, n. 4, p. 587, doi. 10.1007/s11523-024-01065-w
    By:
    • Fiala, Ondřej;
    • Buti, Sebastiano;
    • Bamias, Aristotelis;
    • Massari, Francesco;
    • Pichler, Renate;
    • Maruzzo, Marco;
    • Grande, Enrique;
    • De Giorgi, Ugo;
    • Molina-Cerrillo, Javier;
    • Seront, Emmanuel;
    • Calabrò, Fabio;
    • Myint, Zin W.;
    • Facchini, Gaetano;
    • Kopp, Ray Manneh;
    • Berardi, Rossana;
    • Kucharz, Jakub;
    • Vitale, Maria Giuseppa;
    • Pinto, Alvaro;
    • Formisano, Luigi;
    • Büttner, Thomas
    Publication type:
    Article
    24

    Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study.

    Published in:
    Targeted Oncology, 2023, v. 18, n. 4, p. 559, doi. 10.1007/s11523-023-00978-2
    By:
    • Santoni, Matteo;
    • Massari, Francesco;
    • Myint, Zin W.;
    • Iacovelli, Roberto;
    • Pichler, Martin;
    • Basso, Umberto;
    • Kopecky, Jindrich;
    • Kucharz, Jakub;
    • Buti, Sebastiano;
    • Rizzo, Mimma;
    • Galli, Luca;
    • Büttner, Thomas;
    • De Giorgi, Ugo;
    • Kanesvaran, Ravindran;
    • Fiala, Ondřej;
    • Grande, Enrique;
    • Zucali, Paolo Andrea;
    • Fornarini, Giuseppe;
    • Bourlon, Maria T.;
    • Scagliarini, Sarah
    Publication type:
    Article
    25

    Concomitant Use of Statins, Metformin, or Proton Pump Inhibitors in Patients with Advanced Renal Cell Carcinoma Treated with First-Line Combination Therapies.

    Published in:
    2022
    By:
    • Santoni, Matteo;
    • Molina-Cerrillo, Javier;
    • Myint, Zin W.;
    • Massari, Francesco;
    • Buchler, Tomas;
    • Buti, Sebastiano;
    • Matrana, Marc R.;
    • De Giorgi, Ugo;
    • Rizzo, Mimma;
    • Zabalza, Ignacio Ortego;
    • Galli, Luca;
    • Zucali, Paolo Andrea;
    • Aurilio, Gaetano;
    • Incorvaia, Lorena;
    • Bassanelli, Maria;
    • Mammone, Giulia;
    • Salfi, Alessia;
    • Isella, Luca;
    • Mollica, Veronica;
    • Grande, Enrique
    Publication type:
    journal article
    26
    27

    Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study.

    Published in:
    Targeted Oncology, 2021, v. 16, n. 5, p. 625, doi. 10.1007/s11523-021-00828-z
    By:
    • Santoni, Matteo;
    • Massari, Francesco;
    • Grande, Enrique;
    • Procopio, Giuseppe;
    • Matrana, Marc R.;
    • Rizzo, Mimma;
    • De Giorgi, Ugo;
    • Basso, Umberto;
    • Milella, Michele;
    • Iacovelli, Roberto;
    • Aurilio, Gaetano;
    • Incorvaia, Lorena;
    • Buti, Sebastiano;
    • Caffo, Orazio;
    • Fornarini, Giuseppe;
    • Carrozza, Francesco;
    • Mollica, Veronica;
    • Rizzo, Alessandro;
    • Farag, Fady;
    • Molina-Cerrillo, Javier
    Publication type:
    Article
    28

    Correction to: Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis.

    Published in:
    2020
    By:
    • Iacovelli, Roberto;
    • Ciccarese, Chiara;
    • Facchini, Gaetano;
    • Milella, Michele;
    • Urbano, Federica;
    • Basso, Umberto;
    • De Giorgi, Ugo;
    • Sabbatini, Roberto;
    • Santini, Daniele;
    • Berardi, Rossana;
    • Santoni, Matteo;
    • Bracarda, Sergio;
    • Massari, Francesco;
    • Masini, Cristina;
    • De Tursi, Michele;
    • Ricotta, Riccardo;
    • Buti, Sebastiano;
    • Zustovich, Fable;
    • Sepe, Pierangela;
    • Rossetti, Sabrina
    Publication type:
    Correction Notice
    29

    Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis.

    Published in:
    2020
    By:
    • Iacovelli, Roberto;
    • Ciccarese, Chiara;
    • Facchini, Gaetano;
    • Milella, Michele;
    • Urbano, Federica;
    • Basso, Umberto;
    • De Giorgi, Ugo;
    • Sabbatini, Roberto;
    • Santini, Daniele;
    • Berardi, Rossana;
    • Santoni, Matteo;
    • Bracarda, Sergio;
    • Massari, Francesco;
    • Masini, Cristina;
    • De Tursi, Michele;
    • Ricotta, Riccardo;
    • Buti, Sebastiano;
    • Zustovich, Fable;
    • Sepe, Pierangela;
    • Rossetti, Sabrina
    Publication type:
    journal article
    30
    31
    32
    33

    Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis.

    Published in:
    2016
    By:
    • Massari, Francesco;
    • Ciccarese, Chiara;
    • Caliò, Anna;
    • Munari, Enrico;
    • Cima, Luca;
    • Porcaro, Antonio;
    • Novella, Giovanni;
    • Artibani, Walter;
    • Sava, Teodoro;
    • Eccher, Albino;
    • Ghimenton, Claudio;
    • Bertoldo, Francesco;
    • Scarpa, Aldo;
    • Sperandio, Nicola;
    • Porta, Camillo;
    • Bronte, Vincenzo;
    • Chilosi, Marco;
    • Bogina, Giuseppe;
    • Zamboni, Giuseppe;
    • Tortora, Giampaolo
    Publication type:
    journal article
    34

    Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy.

    Published in:
    2015
    By:
    • Santoni, Matteo;
    • Buti, Sebastiano;
    • Conti, Alessandro;
    • Porta, Camillo;
    • Procopio, Giuseppe;
    • Sternberg, Cora;
    • Bracarda, Sergio;
    • Basso, Umberto;
    • Giorgi, Ugo;
    • Rizzo, Mimma;
    • Derosa, Lisa;
    • Ortega, Cinzia;
    • Massari, Francesco;
    • Milella, Michele;
    • Bersanelli, Melissa;
    • Cerbone, Linda;
    • Muzzonigro, Giovanni;
    • Burattini, Luciano;
    • Montironi, Rodolfo;
    • Santini, Daniele
    Publication type:
    journal article
    35

    The route to personalized medicine in bladder cancer: where do we stand?

    Published in:
    Targeted Oncology, 2015, v. 10, n. 3, p. 325, doi. 10.1007/s11523-015-0357-x
    By:
    • Massari, Francesco;
    • Ciccarese, Chiara;
    • Santoni, Matteo;
    • Brunelli, Matteo;
    • Conti, Alessandro;
    • Modena, Alessandra;
    • Montironi, Rodolfo;
    • Santini, Daniele;
    • Cheng, Liang;
    • Martignoni, Guido;
    • Cascinu, Stefano;
    • Tortora, Giampaolo
    Publication type:
    Article
    36
    37
    38

    Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON- 1 study.

    Published in:
    Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04019-x
    By:
    • Porta, Camillo;
    • Massari, Francesco;
    • Taha, Tarek;
    • Grande, Enrique;
    • Bourlon, Maria T.;
    • Kanesvaran, Ravindran;
    • Basso, Umberto;
    • Molina-Cerrillo, Javier;
    • Alonso-Gordoa, Teresa;
    • Myint, Zin W.;
    • Fornarini, Giuseppe;
    • Buttner, Thomas;
    • Park, Se Hoon;
    • Ürün, Yüksel;
    • De Giorgi, Ugo;
    • Pichler, Renate;
    • Rescigno, Pasquale;
    • Buchler, Tomas;
    • Studentova, Hana;
    • Melichar, Bohuslav
    Publication type:
    Article
    39

    First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study.

    Published in:
    Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03897-x
    By:
    • Roviello, Giandomenico;
    • Molina-Cerrillo, Javier;
    • Massari, Francesco;
    • Cerbone, Linda;
    • Fiala, Ondrej;
    • Fornarini, Giuseppe;
    • Monteiro, Fernando Sabino Marques;
    • Cattrini, Carlo;
    • Landmesser, Johannes;
    • Messina, Carlo;
    • Zgura, Anca;
    • Rebuzzi, Sara Elena;
    • Soares, Andrey;
    • Carrozza, Francesco;
    • Ansari, Jawaher;
    • Grillone, Francesco;
    • Küronya, Zsófia;
    • Incorvaia, Lorena;
    • Bhuva, Dipen;
    • Ortega, Cinzia
    Publication type:
    Article
    40

    Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 8, p. 1, doi. 10.1007/s00262-024-03719-0
    By:
    • Incorvaia, Lorena;
    • Monteiro, Fernando Sabino Marques;
    • Massari, Francesco;
    • Park, Se Hoon;
    • Roviello, Giandomenico;
    • Fiala, Ondřej;
    • Myint, Zin W.;
    • Kucharz, Jakub;
    • Molina-Cerrillo, Javier;
    • Santini, Daniele;
    • Buttner, Thomas;
    • Poprach, Alexandr;
    • Kopecky, Jindrich;
    • Zeppellini, Annalisa;
    • Pichler, Martin;
    • Buchler, Tomas;
    • Pichler, Renate;
    • Facchini, Gaetano;
    • Fay, Andre Poisl;
    • Soares, Andrey
    Publication type:
    Article
    41

    Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03682-w
    By:
    • Massari, Francesco;
    • Santoni, Matteo;
    • Takeshita, Hideki;
    • Okada, Yohei;
    • Tapia, Jose Carlos;
    • Basso, Umberto;
    • Maruzzo, Marco;
    • Scagliarini, Sarah;
    • Büttner, Thomas;
    • Fornarini, Giuseppe;
    • Myint, Zin W.;
    • Galli, Luca;
    • Souza, Vinicius Carrera;
    • Pichler, Renate;
    • De Giorgi, Ugo;
    • Gandur, Nathalia;
    • Lam, Elaine T.;
    • Gilbert, Danielle;
    • Popovic, Lazar;
    • Grande, Enrique
    Publication type:
    Article
    42

    Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3665, doi. 10.1007/s00262-023-03518-z
    By:
    • Fiala, Ondřej;
    • Buti, Sebastiano;
    • Takeshita, Hideki;
    • Okada, Yohei;
    • Massari, Francesco;
    • Palacios, Georgia Anguera;
    • Dionese, Michele;
    • Scagliarini, Sarah;
    • Büttner, Thomas;
    • Fornarini, Giuseppe;
    • Myint, Zin W.;
    • Galli, Luca;
    • Souza, Vinicius Carrera;
    • Pichler, Renate;
    • De Giorgi, Ugo;
    • Quiroga, María Natalia Gandur;
    • Gilbert, Danielle;
    • Popovic, Lazar;
    • Grande, Enrique;
    • Mammone, Giulia
    Publication type:
    Article
    43

    Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 9, p. 2961, doi. 10.1007/s00262-023-03469-5
    By:
    • Santoni, Matteo;
    • Myint, Zin W.;
    • Büttner, Thomas;
    • Takeshita, Hideki;
    • Okada, Yohei;
    • Lam, Elaine T.;
    • Gilbert, Danielle;
    • Küronya, Zsófia;
    • Tural, Deniz;
    • Pichler, Renate;
    • Grande, Enrique;
    • Crabb, Simon J.;
    • Kemp, Robert;
    • Massari, Francesco;
    • Scagliarini, Sarah;
    • Iacovelli, Roberto;
    • Vau, Nuno;
    • Basso, Umberto;
    • Maruzzo, Marco;
    • Molina-Cerrillo, Javier
    Publication type:
    Article
    44
    45

    Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1365, doi. 10.1007/s00262-022-03349-4
    By:
    • Santoni, Matteo;
    • Rizzo, Alessandro;
    • Kucharz, Jakub;
    • Mollica, Veronica;
    • Rosellini, Matteo;
    • Marchetti, Andrea;
    • Tassinari, Elisa;
    • Monteiro, Fernando Sabino Marques;
    • Soares, Andrey;
    • Molina-Cerrillo, Javier;
    • Grande, Enrique;
    • Battelli, Nicola;
    • Massari, Francesco
    Publication type:
    Article
    46
    47
    48

    Ancient DNA SNP-panel data suggests stability in bluefin tuna genetic diversity despite centuries of fluctuating catches in the eastern Atlantic and Mediterranean.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-99708-9
    By:
    • Andrews, Adam J.;
    • Puncher, Gregory N.;
    • Bernal-Casasola, Darío;
    • Di Natale, Antonio;
    • Massari, Francesco;
    • Onar, Vedat;
    • Toker, Nezir Yaşar;
    • Hanke, Alex;
    • Pavey, Scott A.;
    • Savojardo, Castrense;
    • Martelli, Pier Luigi;
    • Casadio, Rita;
    • Cilli, Elisabetta;
    • Morales-Muñiz, Arturo;
    • Mantovani, Barbara;
    • Tinti, Fausto;
    • Cariani, Alessia
    Publication type:
    Article
    49

    Is There a Role for Immunotherapy in Prostate Cancer?

    Published in:
    Cells (2073-4409), 2020, v. 9, n. 9, p. 2051, doi. 10.3390/cells9092051
    By:
    • Rizzo, Alessandro;
    • Mollica, Veronica;
    • Cimadamore, Alessia;
    • Santoni, Matteo;
    • Scarpelli, Marina;
    • Giunchi, Francesca;
    • Cheng, Liang;
    • Lopez-Beltran, Antonio;
    • Fiorentino, Michelangelo;
    • Montironi, Rodolfo;
    • Massari, Francesco
    Publication type:
    Article
    50